Dermatology Medical News about melanoma

Become a Member Today!
Register

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. 2008 Exclusive Survey—Earnings: Good news for primary care income

3. Medicare pay-for-reporting effort draws fire from frustrated doctors

4. Debunking Myths in the US Healthcare System

5. Doctors and the DEA Free full text

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Use of liposomes as drug delivery vehicles for treatment of melanoma
Pigment Cell & Melanoma Research, 06/24/09

Robertson GP et al. - Liposomes delivering chemotherapies, siRNA, asODNs, DNA, and radioactive particles are just some of the promising new nanotechnology based therapies under development for the treatment of melanoma that are discussed in this review.

Exclusive Author Commentary
G. P. Robertson, 06/24/09

This article is useful to persons developing new therapies to treat patients suffering from malignant melanoma. Nanotechnology, and in particular liposomes, has potential to load multiple targeted therapies, which is believed to be needed for the successful management of this disease. These concepts are reviewed in this article.

<< Previous
Drug-induced Pruritus: A Review

Next >>
Statin use and risk of basal cell carcinoma